I am an expert in neurodegenerative disease research with a strong entrepreneurial background, comprehensive business education, and a resolute mission to pioneer life-changing therapies for patients. As an R&D Director, my expertise spans the development of translationally-relevant preclinical models for drug discovery, optimization of iPSC differentiation into dopaminergic neurons, and the preclinical development of biologics for Parkinson's disease. As a startup co-founder, I successfully developed a complex portfolio of R&D programs while taking the lead in driving the company's overall business development, fundraising, and partnering efforts.
